Head-to-head comparisons of medication uses, side effects, warnings, and more.
Velcade (bortezomib) and bexarotene (Targretin) are both used to treat different types of cancer but work in distinct ways and have different uses. Velcade is an injectable medication used to treat multiple myeloma and mantle cell lymphoma, whereas bexarotene is taken orally to treat cutaneous T-cell lymphoma, particularly when other treatments have failed. Diarrhea, nausea, and numbness or tingling of hands or feet are common side effects of Velcade, while nerve, heart, and lung problems are possible, but rare. Common side effects of bexarotene are high fat and cholesterol levels, underactive thyroid, and weakness. Liver problems and inflammation of the pancreas are also possible. Neither medication is safe to use during pregnancy or while breastfeeding and have lower-cost generic forms available.
Velcade (bortezomib) is a recommended anticancer treatment option for multiple myeloma and mantle cell lymphoma in adults. It's given as an injection under the skin (subcutaneously) or into a vein (intravenous, IV) by a healthcare provider. But, it can cause new or worsening numbness and tingling in your hands and feet, which can be bothersome.
Bexarotene (Targretin) is an oral retinoid medication used to treat a rare skin cancer called cutaneous T-cell lymphoma (CTCL) in adults. It’s a type of chemotherapy, usually prescribed when other treatments have stopped working. You take the dose once a day with food, and you’ll need regular blood tests to check for side effects. Common side effects include headache, feeling very tired or low on energy, and high cholesterol levels in the blood.
^*Some side effects listed above might not be from Velcade (bortezomib) alone, since some studies included people taking Velcade (bortezomib) with other anticancer medications.^
^**Less nerve problems seen when injected under the skin versus IV.^
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.